← Back to Clinical Trials
Recruiting NCT00398177

NCT00398177 Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT00398177
Status Recruiting
Phase —
Sponsor Stanford University
Condition Lymphoma, Non-Hodgkin
Study Type OBSERVATIONAL
Enrollment 9,999 participants
Start Date 1999-01
Primary Completion 2099-01

Trial Parameters

Condition Lymphoma, Non-Hodgkin
Sponsor Stanford University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 9,999
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 1999-01
Completion 2099-01

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade. * Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea). * A routine procedure for tissue collection is planned. * Ability to understand and the willingness to sign a written informed consent. Exclusion Criteria: * Patients without NHL or Hodgkin's disease

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE LYMPHOMA, NON-HODGKIN TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology